Find Scholarly Works

Search concepts
Selected Filters
2013
26 Citations (Scopus)

Inflammatory bowel disease in primary sclerosing cholangitis: A robust yet changing relationship

Sinakos, E., Samuel, S., Enders, F., Loftus, E. V., Sandborn, W. J. & Lindor, K., Apr 2013, In : Inflammatory Bowel Diseases. 19, 5, p. 1004-1009 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Ileitis
Immunologic Factors
Alkaline Phosphatase
51 Citations (Scopus)

NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients

Treeprasertsuk, S., Björnsson, E., Enders, F., Suwanwalaikorn, S. & Lindor, K., 2013, In : World Journal of Gastroenterology. 19, 8, p. 1219-1229 11 p.

Research output: Contribution to journalArticle

Liver Cirrhosis
Mortality
Liver
Fibrosis
Coronary Disease
188 Citations (Scopus)

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management

Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J. & Lindor, K., Sep 2013, In : Gastroenterology. 145, 3, p. 521-536 16 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Biliary Tract
Fibrosis
Inflammation
Cholestasis
257 Citations (Scopus)

Primary sclerosing cholangitis

Hirschfield, G. M., Karlsen, T. H., Lindor, K. & Adams, D. H., 2013, In : The Lancet. 382, 9904, p. 1587-1599 13 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
End Stage Liver Disease
Cholangitis
Biliary Liver Cirrhosis
41 Citations (Scopus)

Primary sclerosing cholangitis: A review and update on therapeutic developments

Tabibian, J. H. & Lindor, K., Feb 2013, In : Expert Review of Gastroenterology and Hepatology. 7, 2, p. 103-114 12 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Clinical Trials
Therapeutics
Common Hepatic Duct
End Stage Liver Disease

Primary Sclerosing Cholangitis

Eaton, J. E., Talwalkar, J. A. & Lindor, K., Dec 2013, The Autoimmune Diseases: Fifth Edition. Elsevier Inc., p. 925-936 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Fibrosis
Intrahepatic Bile Ducts
Extrahepatic Bile Ducts
111 Citations (Scopus)

Randomised clinical trial: Vancomycin or metronidazole in patients with primary sclerosing cholangitis - A pilot study

Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A. & Lindor, K., Mar 2013, In : Alimentary Pharmacology and Therapeutics. 37, 6, p. 604-612 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Metronidazole
Vancomycin
Randomized Controlled Trials
Alkaline Phosphatase
43 Citations (Scopus)

Role of the microbiota and antibiotics in primary sclerosing cholangitis

Tabibian, J. H., Talwalkar, J. A. & Lindor, K., 2013, In : BioMed Research International. 2013, 389537.

Research output: Contribution to journalArticle

Drug therapy
Sclerosing Cholangitis
Microbiota
Anti-Bacterial Agents
Liver
15 Citations (Scopus)

Secondary Sclerosing Cholangitis. Pathogenesis, Diagnosis, and Management.

Imam, M. H., Talwalkar, J. A. & Lindor, K., May 2013, In : Clinics in Liver Disease. 17, 2, p. 269-277 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Disease Management
Rare Diseases
Liver Transplantation
Acquired Immunodeficiency Syndrome
2012
3 Citations (Scopus)

A 42-Year-Old Woman With a New Diagnosis of Sclerosing Cholangitis

Gossard, A. A. & Lindor, K., Jun 2012, In : Clinical Gastroenterology and Hepatology. 10, 6, p. 593-597 5 p.

Research output: Contribution to journalArticle

Magnetic Resonance Cholangiopancreatography
Sclerosing Cholangitis
Histocytochemistry
Microscopy
Liver
31 Citations (Scopus)

Autoimmune hepatitis: A review

Gossard, A. A. & Lindor, K., May 2012, In : Journal of Gastroenterology. 47, 5, p. 498-503 6 p.

Research output: Contribution to journalArticle

Autoimmune Hepatitis
Immunosuppressive Agents
Aspartate Aminotransferases
Rare Diseases
Life Expectancy
86 Citations (Scopus)

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Tsuda, M., Moritoki, Y., Lian, Z. X., Zhang, W., Yoshida, K., Wakabayashi, K., Yang, G. X., Nakatani, T., Vierling, J., Lindor, K., Gershwin, M. E. & Bowlus, C. L., Feb 2012, In : Hepatology. 55, 2, p. 512-521 10 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
B-Lymphocytes
T-Lymphocytes
Immunoglobulin M
19 Citations (Scopus)

Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., 2012, In : Journal of Analytical Oncology. 1, 1, p. 50-55 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Common Hepatic Duct
End Stage Liver Disease
Bile Ducts
12 Citations (Scopus)

Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons

Carey, E. J. & Lindor, K., Sep 2012, In : Clinics and Research in Hepatology and Gastroenterology. 36, SUPPL.1

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Chemoprevention
Bile Acids and Salts
Colorectal Neoplasms
Sclerosing Cholangitis
25 Citations (Scopus)

Current pharmacotherapy for cholestatic liver disease

Carey, E. J. & Lindor, K., Dec 2012, In : Expert Opinion on Pharmacotherapy. 13, 17, p. 2473-2484 12 p.

Research output: Contribution to journalArticle

Liver Diseases
Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Drug Therapy
Sclerosing Cholangitis
8 Citations (Scopus)

Evaluating sex and gender competencies in the medical curriculum: A case study

Miller, V. M., Flynn, P. M. & Lindor, K., Jun 2012, In : Gender Medicine. 9, 3

Research output: Contribution to journalArticle

Curriculum
Students
curriculum
gender
Medicine

Gall bladder polyps in primary sclerosing cholangitis: Adhere to the guidelines

Gores, G., Lindor, K. & Razumilava, N., Jul 2012, In : Hepatology. 56, 1, p. 396 1 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Polyps
Urinary Bladder
Guidelines

Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis?

Sinakos, E. & Lindor, K., Jan 30 2012, Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, p. 156-158 3 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ursodeoxycholic Acid
Sclerosing Cholangitis
Inflammatory Bowel Diseases
Colorectal Neoplasms
Therapeutics
43 Citations (Scopus)

Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis

Eaton, J. E., Thackeray, E. W. & Lindor, K., Mar 2012, In : American Journal of Gastroenterology. 107, 3, p. 431-439 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholecystectomy
Polyps
Gallbladder
Neoplasms
12 Citations (Scopus)

Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma

Imam, M. H., Silveira, M. G., Sinakos, E., Gossard, A. A., Jorgensen, R., Keach, J., DeCook, A. C. & Lindor, K., Feb 2012, In : Clinical Gastroenterology and Hepatology. 10, 2, p. 182-185 4 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Hepatocellular Carcinoma
Survival
Liver Transplantation
Odds Ratio
35 Citations (Scopus)

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E. & Lindor, K., May 2012, In : Liver International. 32, 5, p. 790-795 6 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Biomarkers
Clinical Trials
Ursodeoxycholic Acid
Therapeutics
2 Citations (Scopus)

Outcome of gallbladder polyps in patients with primary sclerosing cholangitis

Treeprasertsuk, S., Sinakos, E., Keach, J. & Lindor, K., Dec 2012, In : Asian Biomedicine. 6, 6, p. 849-857 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Polyps
Gallbladder
Cholecystectomy
Liver
27 Citations (Scopus)

Pathogenesis and management of pruritus in cholestatic liver disease

Imam, M. H., Gossard, A. A., Sinakos, E. & Lindor, K., 2012, In : Journal of Gastroenterology and Hepatology (Australia). 27, 7, p. 1150-1158 9 p.

Research output: Contribution to journalArticle

Pruritus
Liver Diseases
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Cholestasis
30 Citations (Scopus)

Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

Mendes, F. D., Suzuki, A., Sanderson, S. O., Lindor, K. & Angulo, P., Sep 2012, In : Clinical Gastroenterology and Hepatology. 10, 9

Research output: Contribution to journalArticle

Portal Hypertension
Fibrosis
Esophageal and Gastric Varices
Splenomegaly
Non-alcoholic Fatty Liver Disease

Primary Biliary Cirrhosis

Lindor, K. & Levy, C., 2012, Zakim and Boyer's Hepatology. Elsevier Inc., p. 738-753 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Biliary Liver Cirrhosis

Primary sclerosing cholangitis

Treeprasertsuk, S. & Lindor, K., Apr 16 2012, Textbook of Clinical Gastroenterology and Hepatology: Second Edition. Wiley-Blackwell, p. 573-579 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Survival
Ursodeoxycholic Acid
Cholangiocarcinoma

Primary sclerosing cholangitis: Providing a safe and effective treatment

Imam, M. H. & Lindor, K., Jun 2012, In : Expert Review of Gastroenterology and Hepatology. 6, 3, p. 255-257 3 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Sclerosing Cholangitis
End Stage Liver Disease
Docosahexaenoic Acids
1 Citation (Scopus)

Recent developments in the management of idiopathic cholestatic liver disease

Imam, M. H., Weeding, E. & Lindor, K., 2012, In : Annals of Gastroenterology. 25, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

Touch
Liver Diseases
Therapeutics
10 Citations (Scopus)

Serum lipids in primary sclerosing cholangitis

Sinakos, E., Abbas, G., Jorgensen, R. A. & Lindor, K., Jan 2012, In : Digestive and Liver Disease. 44, 1, p. 44-48 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Lipids
Serum
LDL Cholesterol
Ursodeoxycholic Acid
79 Citations (Scopus)

The Framingham risk score and heart disease in nonalcoholic fatty liver disease

Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K., St Sauver, J. & Angulo, P., Jul 2012, In : Liver International. 32, 6, p. 945-950 6 p.

Research output: Contribution to journalArticle

Coronary Disease
Heart Diseases
Non-alcoholic Fatty Liver Disease
Longitudinal Studies
24 Citations (Scopus)

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - A pilot study

Martin, C. R., Blanco, P. G., Keach, J. C., Petz, J. L., Zaman, M. M., Bhaskar, K. R., Cluette-Brown, J. E., Gautam, S., Sheth, S., Afdhal, N. H., Lindor, K. & Freedman, S. D., Jan 2012, In : Alimentary Pharmacology and Therapeutics. 35, 2, p. 255-265 11 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Docosahexaenoic Acids
Safety
Alkaline Phosphatase
Cystic Fibrosis Transmembrane Conductance Regulator
14 Citations (Scopus)

The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease

Charatcharoenwitthaya, P., Lindor, K. & Angulo, P., Jul 2012, In : Digestive Diseases and Sciences. 57, 7, p. 1925-1931 7 p.

Research output: Contribution to journalArticle

Liver
Enzymes
Body Weight Changes
Transaminases
Non-alcoholic Fatty Liver Disease
2011
92 Citations (Scopus)

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K., Apr 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Ursodeoxycholic Acid
Cholangiocarcinoma
Serum
12 Citations (Scopus)

A major step towards effective treatment evaluation in primary biliary cirrhosis

Beuers, U. & Lindor, K., Dec 2011, In : Journal of Hepatology. 55, 6, p. 1178-1180 3 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Biliary Liver Cirrhosis
9 Citations (Scopus)

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

Medical Schools
Medical Students
Students
medical student
school
16 Citations (Scopus)

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K., May 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Anti-Bacterial Agents
Therapeutics
Bacteremia
Bile Ducts

Autoimmune liver diseases

Abbas, G. & Lindor, K., Jan 2011, Autoimmune Disorders: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., p. 1-34 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Autoimmune Diseases
Biliary Liver Cirrhosis
Liver Diseases
53 Citations (Scopus)

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Cell- and Tissue-Based Therapy
B-Lymphocytes
Cholangitis
Antibodies
56 Citations (Scopus)

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Bone Diseases
Osteoporosis
Inflammatory Bowel Diseases
Confidence Intervals
158 Citations (Scopus)

Cancer surveillance in patients with primary sclerosing cholangitis

Razumilava, N., Gores, G. J. & Lindor, K., Nov 2011, In : Hepatology. 54, 5, p. 1842-1852 11 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Gallbladder Neoplasms
Neoplasms
Cholangiocarcinoma
Inflammatory Bowel Diseases
44 Citations (Scopus)

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K., Jan 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Colonic Neoplasms
Guidelines
Colonoscopy
25 Citations (Scopus)

Current management of primary sclerosing cholangitis in pediatric patients

Ibrahim, S. H. & Lindor, K., 2011, In : Pediatric Drugs. 13, 2, p. 87-95 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Pediatrics
Ursodeoxycholic Acid
End Stage Liver Disease
Cholangiography
17 Citations (Scopus)

Current therapies for nonalcoholic fatty liver disease

Gossard, A. A. & Lindor, K., Dec 2011, In : Drugs of Today. 47, 12, p. 915-922 8 p.

Research output: Contribution to journalArticle

Exercise
Weight Loss
Therapeutics
End Stage Liver Disease
Bariatric Surgery

Eyewitnesses to history and participants as well

Lindor, K., Dec 2011, In : Hepatology. 54, 6, p. 1897 1 p.

Research output: Contribution to journalArticle

History
38 Citations (Scopus)

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K., May 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Liver Diseases
Therapeutic Uses
Cytoplasmic and Nuclear Receptors
Bile Acids and Salts
113 Citations (Scopus)

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

academic career
gender-specific factors
Appointments and Schedules
productivity
physician
18 Citations (Scopus)

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K., Nov 2011, In : American Journal of Therapeutics. 18, 6

Research output: Contribution to journalArticle

Renin-Angiotensin System
Fibrosis
Liver
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
57 Citations (Scopus)

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K., Nov 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Bilirubin
Placebos
Cholangiocarcinoma
154 Citations (Scopus)

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J. & Lindor, K., Sep 2011, In : American Journal of Gastroenterology. 106, 9, p. 1638-1645 8 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Ulcerative Colitis
Neoplasms
Colorectal Neoplasms
6 Citations (Scopus)

Immunoglobulin G4-associated autoimmune cholangiopathy

Lindor, K., Apr 2011, In : Gastroenterology and Hepatology. 7, 4, p. 259-261 3 p.

Research output: Contribution to journalArticle

Immunoglobulins